Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

CXA-10, a Nitrated Fatty Acid, Is Renoprotective in Deoxycorticosterone Acetate-Salt Nephropathy.

Arbeeny CM, Ling H, Smith MM, O'Brien S, Wawersik S, Ledbetter SR, McAlexander A, Schopfer FJ, Willette RN, Jorkasky DK.

J Pharmacol Exp Ther. 2019 Jun;369(3):503-510. doi: 10.1124/jpet.118.254755. Epub 2019 Mar 20.

PMID:
30894457
2.

Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase.

Yew NS, Zhao H, Hong EG, Wu IH, Przybylska M, Siegel C, Shayman JA, Arbeeny CM, Kim JK, Jiang C, Cheng SH.

PLoS One. 2010 Jun 21;5(6):e11239. doi: 10.1371/journal.pone.0011239.

3.
4.

BMS-201620: a selective beta 3 agonist.

Washburn WN, Sun CQ, Bisacchi G, Wu G, Cheng PT, Sher PM, Ryono D, Gavai AV, Poss K, Girotra RN, McCann PJ, Mikkilineni AB, Dejneka TC, Wang TC, Merchant Z, Morella M, Arbeeny CM, Harper TW, Slusarchyk DA, Skwish S, Russell AD, Allen GT, Tesfamariam B, Frohlich BH, Abboa-Offei BE, Cap M, Waldron TL, George RJ, Young D, Dickinson KE, Seymour AA.

Bioorg Med Chem Lett. 2004 Jul 5;14(13):3525-9.

PMID:
15177466
5.

BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor.

Gavai AV, Sher PM, Mikkilineni AB, Poss KM, McCann PJ, Girotra RN, Fisher LG, Wu G, Bednarz MS, Mathur A, Wang TC, Sun CQ, Slusarchyk DA, Skwish S, Allen GT, Hillyer DE, Frohlich BH, Abboa-Offei BE, Cap M, Waldron TL, George RJ, Tesfamariam B, Harper TW, Ciosek CP Jr, Young DA, Dickinson KE, Seymour AA, Arbeeny CM, Washburn WN.

Bioorg Med Chem Lett. 2001 Dec 3;11(23):3041-4.

PMID:
11714606
6.

Beta 3 agonists. Part 1: evolution from inception to BMS-194449.

Washburn WN, Sher PM, Poss KM, Girotra RN, McCann PJ, Gavai AV, Mikkilineni AB, Mathur A, Cheng P, Dejneka TC, Sun CQ, Wang TC, Harper TW, Russell AD, Slusarchyk DA, Skwish S, Allen GT, Hillyer DE, Frohlich BH, Abboa-Offei BE, Cap M, Waldron TL, George RJ, Tesfamariam B, Ciosek CP Jr, Ryono D, Young DA, Dickinson KE, Seymour AA, Arbeeny CM, Gregg RE.

Bioorg Med Chem Lett. 2001 Dec 3;11(23):3035-9.

PMID:
11714605
7.

Beta 3-adrenergic receptor-mediated lipolysis and oxygen consumption in brown adipocytes from cynomolgus monkeys.

Meyers DS, Skwish S, Dickinson KE, Kienzle B, Arbeeny CM.

J Clin Endocrinol Metab. 1997 Feb;82(2):395-401.

PMID:
9024225
8.

Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice.

Arbeeny CM, Meyers DS, Hillyer DE, Bergquist KE.

Am J Physiol. 1995 Apr;268(4 Pt 1):E678-84.

PMID:
7733267
9.

Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster.

Arbeeny CM, Meyers DS, Bergquist KE, Gregg RE.

J Lipid Res. 1992 Jun;33(6):843-51.

10.

Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma.

Quig DW, Arbeeny CM, Zilversmit DB.

Biochim Biophys Acta. 1991 Jun 3;1083(3):257-64.

PMID:
2049390
11.

The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits.

Arbeeny CM, Bergquist KE.

Biochim Biophys Acta. 1991 Apr 15;1096(3):238-44.

PMID:
1902119
12.

Effects of fish oil on glomerular function in rats with diabetes mellitus.

Sinha AK, Scharschmidt LA, Neuwirth R, Holthofer H, Gibbons N, Arbeeny CM, Schlondorff D.

J Lipid Res. 1990 Jul;31(7):1219-28.

13.

Hyperlipoproteinemia in spontaneously diabetic guinea pigs.

Arbeeny CM, Nordin C, Edelstein D, Stram N, Gibbons N, Eder HA.

Metabolism. 1989 Sep;38(9):895-900.

PMID:
2770534
14.

Effect of diabetes on the metabolism of triacylglycerol-rich lipoproteins.

Arbeeny CM, Eder HA.

Biochem Soc Trans. 1989 Feb;17(1):51-3. No abstract available.

PMID:
2714517
15.

Determinants of the uptake of very low density lipoprotein remnants by the perfused rat liver.

Arbeeny CM, Rifici VA, Handley DA, Eder HA.

Metabolism. 1987 Nov;36(11):1106-13.

PMID:
3670075
16.

The uptake of the apoprotein and cholesteryl ester of high-density lipoproteins by the perfused rat liver.

Arbeeny CM, Rifici VA, Eder HA.

Biochim Biophys Acta. 1987 Jan 13;917(1):9-17.

PMID:
3790615
17.

Effect of platelet activating factor on endothelial permeability to plasma macromolecules.

Handley DA, Arbeeny CM, Lee ML, Van Valen RG, Saunders RN.

Immunopharmacology. 1984 Dec;8(3-4):137-42.

PMID:
6083990
18.
19.

Removal of lipid-rich lipoproteins by the liver.

Arbeeny CM, Eder HA.

J Lipid Res. 1983 Nov;24(11):1457-67.

20.

Ultrastructure of hepatic cholesterol crystals in the hypercholesterolemic - diabetic rat.

Handley DA, Chien S, Arbeeny CM.

Pathol Res Pract. 1983 Jun;177(1):13-21.

PMID:
6622291
21.
22.

Ultrastructural visualization of low-density lipoproteins during receptor binding and cellular endocytosis.

Handley DA, Arbeeny CM, Witte LD, Goodman DS, Chien S.

J Ultrastruct Res. 1983 Apr;83(1):43-7.

PMID:
6190008
23.
24.

Colloidal gold--low density lipoprotein conjugates as membrane receptor probes.

Handley DA, Arbeeny CM, Witte LD, Chien S.

Proc Natl Acad Sci U S A. 1981 Jan;78(1):368-71.

25.
26.

Serum lipoproteins of diabetic rats fed a high cholesterol diet.

Arbeeny CM, Edelstein D, Freedman SR, Eder HA.

Diabetes. 1980 Oct;29(10):774-7.

PMID:
7002659
27.

The activity and sedimentation properties of the aminoacyl-tRNA synthetases of rat skeletal muscle.

Arbeeny CM, Briden KL, Stirewalt WS.

Biochim Biophys Acta. 1979 Sep 27;564(2):191-201.

PMID:
486478

Supplemental Content

Loading ...
Support Center